Bharat Biotech announced that the price of its Covaxin vaccine for state governments has been reduced from Rs 600 to Rs 400 per dose. The cost of the COVID-19 vaccine has been increased to Rs 1,200 per dose for private hospitals.
The announcement by one of the two companies whose vaccines are approved in India comes a day after the other company, Adar Poonawalla’s Serum Institute of India, reduced the price of its Covishield vaccine from Rs 400 to Rs 300 in a “philanthropic gesture,” according to Mr. Poonawalla.
The topic of vaccine pricing has been hotly debated after the two firms recently set a price for their vaccines in the midst of the pandemic’s deadly second wave. Some politicians and activists have requested that all children be vaccinated for free. The firms, on the other hand, have only recently requested thousands of crores from the government to produce the vaccines.
“Bharat Biotech is extremely worried about the urgent pandemic situation that India is currently experiencing. We have made Covaxin available to state governments at a cost of Rs 400 per dose, in recognition of the immense challenges that the public health care system faces “According to a statement released today by Krishna M Ella’s company.